Apollo Hospitals shares rallies 6% as Q3 profit rises 35% to ₹502 crore

Mumbai | February 11

Shares of Apollo Hospitals Enterprise rose nearly 6% on Wednesday after the company reported strong quarterly results.

The stock touched an intraday high of ₹7,640 on the NSE and was trading around ₹7,600 in early trade.

Q3 FY26 consolidated results

For the quarter ended December 2025, Apollo Hospitals posted a consolidated net profit of ₹502.3 crore, up 34.9% from ₹372.3 crore a year ago.

Revenue from operations increased 17.19% to ₹6,477.4 crore, compared with ₹5,526.9 crore in the same quarter last year.

EBITDA rose 27% to ₹965 crore. Margin improved to 14.9% from 13.78% a year earlier.

The board declared an interim dividend of ₹10 per share for FY26. The record date is February 16.

Hospital segment performance

Revenue from the hospital services segment rose 14% to ₹3,183 crore. EBITDA from this division increased 18% to ₹790 crore. Margins improved to 24.8%. Profit after tax from healthcare services rose 21% to ₹422 crore.

As of December 2025, the company operated 8,072 beds across its network. Occupancy stood at 67%. During the quarter, Apollo opened a 250-bed hospital in Pune.

Other businesses

Apollo HealthCo, which runs the digital health and pharmacy business, reported revenue of ₹2,827 crore, up 20%. EBITDA more than doubled to ₹128 crore from ₹57 crore last year. Margins improved to 4.5%. Profit after tax rose to ₹87 crore from ₹32 crore a year ago.

Apollo Health and Lifestyle, which includes diagnostics and retail healthcare, posted revenue of ₹467 crore, also up 20% YoY. EBITDA rose 39% to ₹48 crore. Margins expanded to 10.2%.

Stock performance and PL Capital View

Stock gained over 5% in early trading session. In the last five trading sessions, Apollo Hospitals shares have gained over 6%. Over the past one year, the stock has risen nearly 20%.

PL Capital maintains a BUY rating on Apollo Hospitals with a target price of ₹8,600.

For all market-related updates, follow PL Capital.